Salvatore Calabrese - Chief Financial Officer at Gain Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
GANX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Salvatore Calabrese since 11/5/2023

Holdings reported by Salvatore Calabrese for Gain Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 25K $62.5K $2.50 Mar 23, 2023 Direct Common Stock
Employee Stock Option (right to buy) 50K Mar 23, 2023 Direct Common Stock

Transactions reported by Salvatore Calabrese for Gain Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.